ULK1 and hepatocellular carcinoma: Interestingly, a more recent study suggested that compound SBI-0206965 which is a highly selective ULK1 inhibitor may have promise as a more specific inhibitor of autophagy in the treatment of HCC, potentially in combination with mTOR inhibitor [127].